[go: up one dir, main page]

WO2007033369A3 - Evaluation du risque de thrombose vasculaire cerebrale par mesure de c4d sur les plaquettes - Google Patents

Evaluation du risque de thrombose vasculaire cerebrale par mesure de c4d sur les plaquettes Download PDF

Info

Publication number
WO2007033369A3
WO2007033369A3 PCT/US2006/036007 US2006036007W WO2007033369A3 WO 2007033369 A3 WO2007033369 A3 WO 2007033369A3 US 2006036007 W US2006036007 W US 2006036007W WO 2007033369 A3 WO2007033369 A3 WO 2007033369A3
Authority
WO
WIPO (PCT)
Prior art keywords
platelets
measuring
assessing risk
cerebrovascular thrombosis
risk
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2006/036007
Other languages
English (en)
Other versions
WO2007033369A2 (fr
Inventor
Joseph M Ahearn
Susan M Manzi
Amy Kao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pittsburgh
Original Assignee
University of Pittsburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Pittsburgh filed Critical University of Pittsburgh
Publication of WO2007033369A2 publication Critical patent/WO2007033369A2/fr
Publication of WO2007033369A3 publication Critical patent/WO2007033369A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/22—Haematology
    • G01N2800/226—Thrombotic disorders, i.e. thrombo-embolism irrespective of location/organ involved, e.g. renal vein thrombosis, venous thrombosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Test d'évaluation pratique, économique et réactif pour l'évaluation du risque d'accident thrombotique chez un sujet ; plus précisément, il a été établi que les personnes à risque dans le domaine de la thrombose vasculaire cérébrale présentaient un dépôt élevé de C4d sur leurs plaquettes.
PCT/US2006/036007 2005-09-14 2006-09-14 Evaluation du risque de thrombose vasculaire cerebrale par mesure de c4d sur les plaquettes Ceased WO2007033369A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US71752505P 2005-09-14 2005-09-14
US60/717,525 2005-09-14
US52005406A 2006-09-11 2006-09-11
US11/520,054 2006-09-11

Publications (2)

Publication Number Publication Date
WO2007033369A2 WO2007033369A2 (fr) 2007-03-22
WO2007033369A3 true WO2007033369A3 (fr) 2007-11-01

Family

ID=37865605

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/036007 Ceased WO2007033369A2 (fr) 2005-09-14 2006-09-14 Evaluation du risque de thrombose vasculaire cerebrale par mesure de c4d sur les plaquettes

Country Status (1)

Country Link
WO (1) WO2007033369A2 (fr)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976540A (en) * 1993-05-17 1999-11-02 T Cell Sciences, Inc. Compositions comprising complement related proteins and carbohydrates, and methods for producing and using said compositions
US6312693B1 (en) * 1998-02-19 2001-11-06 Alejandro A. Aruffo Antibodies against human CD40
US20020081293A1 (en) * 1998-02-20 2002-06-27 Tanox, Inc., Delaware Corporation Inhibitors of complement activation
US20020192758A1 (en) * 2000-08-01 2002-12-19 Welcher Andrew A. C3b/C4b complement receptor-like molecules and uses thereof
US20040077934A1 (en) * 1999-07-06 2004-04-22 Intercure Ltd. Interventive-diagnostic device
US20050130230A1 (en) * 2003-09-23 2005-06-16 Antoni Davalos Cellular fibronectin as a diagnostic marker in stroke and methods of use thereof

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976540A (en) * 1993-05-17 1999-11-02 T Cell Sciences, Inc. Compositions comprising complement related proteins and carbohydrates, and methods for producing and using said compositions
US6312693B1 (en) * 1998-02-19 2001-11-06 Alejandro A. Aruffo Antibodies against human CD40
US6413514B1 (en) * 1998-02-19 2002-07-02 Bristol-Myers Squibb Company Methods of using antibodies against human CD40
US20020081293A1 (en) * 1998-02-20 2002-06-27 Tanox, Inc., Delaware Corporation Inhibitors of complement activation
US20040077934A1 (en) * 1999-07-06 2004-04-22 Intercure Ltd. Interventive-diagnostic device
US20020192758A1 (en) * 2000-08-01 2002-12-19 Welcher Andrew A. C3b/C4b complement receptor-like molecules and uses thereof
US20050130230A1 (en) * 2003-09-23 2005-06-16 Antoni Davalos Cellular fibronectin as a diagnostic marker in stroke and methods of use thereof

Also Published As

Publication number Publication date
WO2007033369A2 (fr) 2007-03-22

Similar Documents

Publication Publication Date Title
WO2007044763A3 (fr) Systeme et procede permettant la detection de transactions frauduleuses
WO2009087359A3 (fr) Procédé et système d'évaluation d'activité internet
WO2018213604A3 (fr) Dosages de diagnostic pour détecter, quantifier et/ou suivre des microbes et d'autres analytes
TW200728704A (en) Apparatus and method for measuring real-time corrosion
WO2008127226A3 (fr) Antagonistes de kinase p13
TW200626989A (en) Multifocal lenses for pre-presbyopic individuals
IN2014DN05011A (fr)
WO2006066118A3 (fr) Conditionnement contextuel des peurs pour predire l'efficacite immunotherapeutique
WO2008073425A3 (fr) Dosage grande sensibilité de la protéolyse
WO2008122053A3 (fr) Compositions, kits et procédés correspondants pour la détection et/ou le contrôle de pseudomonas aeruginosa
WO2010059242A3 (fr) Compositions diagnostiques de maladie neurodégénérative et procédés d'utilisation
WO2017070114A3 (fr) Biomarqueurs associés au diabète et de traitement d'affections associées au diabète
WO2008029277A3 (fr) Détection d'une interférence de signal dans un système de véhicule
WO2005083445A3 (fr) Methodes de determination des bienfaits relatifs et/ou d'evaluation de changements quantitatifs causes par des produits sur des tissus epitheliaux
WO2009111033A3 (fr) Détection de biomarqueurs et complexes de biomarqueurs
WO2007120316A3 (fr) Systèmes, procédés et appareil de détection de composantes tonales
GB2585258B (en) Mass spectrometric method for determining the presence or absence of a chemical element in an analyte
WO2007092302A3 (fr) dispositif d'essai pour la detection d'analytes
WO2005087793A3 (fr) Compositions immunostimulatrices et leurs utilisations
HK1232290A1 (zh) 检测人类骨膜蛋白的新型测定
DK2327792T3 (da) Fremgangsmåder og sammensætninger til påvisning af autoimmunsygdomme
GB2434685B (en) Method for testing the interconnection of remote hazardous condition detectors
WO2008107570A3 (fr) Dispositif et procede pour evaluer l'exposition sonore d'un individu
WO2007048067A3 (fr) Mutations oncogenes du gene c-kit dans des melanomes
WO2005118516A3 (fr) Methode et appareil permettant de determiner un etat de sante

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06803661

Country of ref document: EP

Kind code of ref document: A2